Ophthalmology Times

Treatment-Resistant AMD Achieving Anatomical and Functional Gains With Aflibercept 8 mg

Treatment-Resistant AMD and Diabetic Macular EdemaWith High-Dose Aflibercept Summary. This presentation examines the ...
Ophthalmology Times

Chronic nAMD With Cataract Complications: Visual Stabilization Through Sequential Anti-VEGF Strategies

This comprehensive presentation examines complex retinal disease management using sequential anti-VEGF therapies, supported ...
Healio

Updates from EURETINA and Retina Society: nAMD and DR/DME Treatment

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Retinal diseases such as neovascular age-related macular ...
Center for Biosimilars

Proposed Aflibercept Biosimilar Shows Comparable Safety, Efficacy in Phase 3 AMD Trial

AVT06, a promising biosimilar to aflibercept (Eylea), shows comparable efficacy and safety for treating neovascular ...
pharmaphorum

IRA negotiated prices revealed as Biden claims $6bn savings

The US government has published the finalised 'maximum fair prices' (MFPs) for the first 10 medicines subject to Medicare negotiations under the Inflation Reduction Act (IRA), shortly after President ...